Delivery Order SPE2DB20D1004-SPE2DB23FF5H2
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,413.58 Firm Fixed Price delivery order is for 60 capsules of 300 mg Rifampin, a medication used to treat infections. The contract has an ultimate completion date of March 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,866.46, is a delivery order for the supply of 60 units of 300 mg Rifampin capsules. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,025.41 firm fixed-price delivery order is for the supply of 4,566,133,790 units of 300 mg Rifampin capsules. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This is a $2,906.17 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 60 capsules of 300 mg rifampin. The contract has an ultimate completion date of March 6, 2024 and was awarded on March 5, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a $5,131.51 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60 capsules of 300 mg Rifampin, a medication used to treat certain bacterial infections. The contract has a performance period extending through July 7, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply Rifampin 300 mg capsules. The contract is valued at $3,894.85 and has a completion date of September 25, 2023. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation indicated. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,996.76 delivery order contract is for the supply of Rifampin 300 mg capsules, a critical antibiotic medication. The contract has a firm fixed-price pricing type and an ultimate completion date of November 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is for the delivery of Rifampin 300mg capsules, a pharmaceutical product, with a ceiling value of $106,743.73 and a performance period through June 18, 2025. The contract is a Firm Fixed Price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,366.09 firm fixed-price delivery order is for the supply of 60 capsules of Rifampin 300 mg, a medication used to treat certain bacterial infections. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 300 mg rifampin capsules. The $2,321.04 firm fixed price contract has an ultimate completion date of August 13, 2024. This order is not associated with a set-aside program. AmerisourceBergen, through its extensive pharmaceutical supply chain network, will provide these critical prescription medications to support military treatment...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB23FF5H2Delivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,405.08 contract is for the delivery of 60 units of 300 mg Rifampin capsules. There is no set-aside designation indicated for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These contracting mechanisms enable efficient government procurement of essential pharmaceutical and medical items for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 3/27/23 |